Metraipolis › archive › dc_fcc66454bd15
Comparison of efficacy of rifaximin, probiotics and L-ornithine L-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled… — Europe PMC PMID:41272855
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41272855
- DOI
- 10.1186/s13063-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T09:00:35.192Z
- SHA-256 of the archived text
faefcc6c0d84a617c9ab3d323c37982dad1ff558a9607249ca999a5336b9c7e4- Stable URL of this page
https://metraipolis.com/documento/dc_fcc66454bd15
How to cite
Comparison of efficacy of rifaximin, probiotics and L-ornithine L-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled… — Europe PMC PMID:41272855 — Europe PMC (en), https://europepmc.org/article/MED/41272855 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcc66454bd15 (Metraipolis archive dc_fcc66454bd15, sha256 faefcc6c0d84a617c9ab3d323c37982dad1ff558a9607249ca999a5336b9c7e4)
BibTeX
@misc{dcfcc66454bd15,
title = {Comparison of efficacy of rifaximin, probiotics and L-ornithine L-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled… — Europe PMC PMID:41272855},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41272855},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcc66454bd15; sha256 faefcc6c0d84a617c9ab3d323c37982dad1ff558a9607249ca999a5336b9c7e4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41272855. Agents can read the archived copy with the MCP tool read_document.